IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 28.96 EUR -0.07% Market Closed

Market Cap: €1.4B

I	ImmunoGen Inc XBER:IMU	US
K	Kerry Group PLC OTC:KRYAF	IE
	Gazprom Neft' PAO MOEX:SIBN	RU
S	Solaredge Technologies Inc F:2ED	IL
N	Nkt A/S F:NKT	DK
	Brighthouse Financial Inc NASDAQ:BHF	US
A	Ageas SA SWB:FO4N	BE
	Alstom SA PAR:ALO	FR
G	Greenbrier Companies Inc F:G90	US
	Galapagos NV OTC:GLPGF	BE
S	Severn Trent PLC DUS:SVT1	UK

Profitability Summary

ImmunoGen Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

91% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-97% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-61%

Net Margin is Increasing

-96% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-105%

Free Cash Flow Margin is Increasing

-140% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-240% > -74%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.